INanoBio
Nanotechnology ResearchArizona, United States11-50 Employees
INanoBio operates in the nanotechnology research field, developing high-accuracy diagnostics for disease at early, pre-symptomatic stages. It combines nanoscale biotechnologies with machine learning to derive scalable insights from complex disease biology and to pinpoint disease-specific molecular biomarkers. The aim is to enable early personalized therapeutic intervention to preempt full disease development. It is based in Scottsdale, Arizona, and employs a small to mid-sized team. Positioned in the nanotechnology research arena, the company focuses on diagnostic tools that may reveal disease signals before symptoms appear. This aligns with broader goals of advancing preemptive medicine.